Atlas Trials

Image-guided De-escalation of Neo-adjuvant Chemotherapy in HER2-positive Breast Cancer: the TRAIN-3 Study

Clinical trial NCT03820063 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03820063
Sponsor
Borstkanker Onderzoek Groep
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2019-02-27
Primary completion
2022-11-15
Enrollment
462

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.